State-of-the-Art Digital Pathology | CellCarta

Études de cas May 31, 2023

The beauty of better results with digital assays and AI-driven image analysis!

State-of-the-Art Digital Pathology

Our 21 CFR-part 11 compliant digital image analysis workflow ensures high-quality clinical insights. We provide detailed H&E and IHC/IF/ISH image analysis using advanced software with AI capabilities to support your clinical studies.

Discover the art of digital analysis!

CellCarta’s digital pathology expertise combines a meticulous digital assay workflow with comprehensive image analysis.

  • Complete H&E evaluations
  • Detailed image annotations
  • Strict quality checks by our analysts and pathologists
  • Easy-to-navigate data reports.

Download the resource

Digital image analysis workflow

As a global CRO, we prioritize your study goals and clinical trial needs above all else. We aim to provide you with easy, accessible, and comprehensive technologies spanning a multitude of therapeutic areas.

Discover our range of services in immunology, proteomics, genomics, as well as related ML/AI and sample logistics services.

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

cta banner